Filing metadata

Accession number
0001562180-25-005390
Form type
Form 4
Filer
EyePoint Pharmaceuticals, Inc.
CIK
CIK 1314102
Filed
Jul 11, 2025
Reporting period
Jul 10, 2025
Description
Insider transaction

Explore SEC Filings Hub